Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Vorasidenib improves response to subsequent chemoradiation in a genetically engineered mouse model of IDH-mutant glioma.
Journal: Science translational medicine
Published: August 05, 2026
The role for surgery in IDH-mutant grade 4 Astrocytomas: interactive effects of resection, patient characteristics, and outcome - report of the RANO resect group.
Journal: Neuro-oncology
Published: June 09, 2026
Contemporary practice patterns in IDH-mutant glioma management: a multidisciplinary multi-institutional survey.
Journal: Journal of neuro-oncology
Published: April 24, 2026
Current and emerging therapies in IDH-mutant glioma.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: March 18, 2026
Evaluation of sex differences in survival among glioblastoma patients treated with immune checkpoint inhibitors.
Journal: Neuro-oncology advances
Published: October 24, 2025
Neuroimaging endpoints for clinical trials in gliomas: the neuro-oncologist perspective.
Journal: Current opinion in neurology
Published: August 07, 2025
Prognostic significance of O6-methylguanine-DNA methyltransferase promoter methylation status in isocitrate dehydrogenase-mutant glioma.
Journal: Neuro-oncology
Published: August 04, 2025
The use of minor response, volumetric assessment, and growth rate kinetics as endpoints in grade 1-3 glioma clinical trials: a RANO perspective.
Journal: Neuro-oncology
Published: July 22, 2025
A pilot study to quantify and describe personal social networks in patients with glioblastoma.
Journal: Neuro-oncology practice
Published: June 09, 2025
Last Updated: 09/26/2026